Samuel Marcrom, MD
Radiation Oncology · Birmingham, ALNPI 1093127425
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,115 of the $1,642 with a category attached, or 67.9%. 8 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 59.8% of the total. Reporting peaked in 2019 at $895 and has fallen 78.1% since, to $196 in 2025.
Across 26 payments — averaging $63.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$982
- Novocure Inc.$290
- Varian Medical Systems, Inc.$238
- Bioprotect Medical, Inc.$53
- Bayer$38
- Regeneron Healthcare Solutions, Inc.$16
- plus $25 from 2 others
Across 7 payments — averaging $20,584 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$144K
What the payments were for
- Travel & lodging$52732%
- Food & beverage$1,11568%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 14 | $982 |
| Novocure Inc. | 4 | $290 |
| Varian Medical Systems, Inc. | 2 | $238 |
| Bioprotect Medical, Inc. | 1 | $53 |
| Bayer | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOMATOM Confidence$433
- Edge$309
- Optune Gio$285
- Calypso System$169
- Eclipse Treatment Planning System for External Beam Radiation Therapy$169
- Varian Ethos Treatment Planning$140
- Varian IDENTIFY$140
- Optune$108
How this compares
$1,642 in reported general payments places this provider in the 55th percentile of 87 radiation oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 42 | $105,863 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Birmingham
- Drexell BoggsBirmingham$35K
- Christopher WilleyBirmingham$13K
- Adam KoleBirmingham$11K
- Andrew McDonaldBirmingham$8K
- William EnnisBirmingham$6K
- John StahlBirmingham$3K
- Omer BurnettBirmingham$2K
- Rojymon JacobBirmingham$1K
- Mehran YusufBirmingham$1K
- Ruby MeredithBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.